FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016029624> ?p ?o ?g. }

• W2016029624 endingPage "177" @default.
• W2016029624 startingPage "170" @default.
• W2016029624 abstract "Abstract. Background. Patients using higher dosages of inhaled or oral glucocorticoids (GCs) have an increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of this increased risk has not been widely studied. Objective. To evaluate the contribution of the underlying disease to the risk of hip/femur fracture in patients using inhaled or oral GCs. Design and subjects. A case–control study within the Dutch PHARMO‐RLS database was conducted. Cases ( n = 6763) were adult patients with a first hip/femur fracture during enrolment. Each case was matched to four controls by age, gender and region. Results. The risk of hip/femur fracture increased with current use of inhaled GCs (crude OR 1.30, 95% CI:1.16–1.47) and with current use of oral GCs (crude OR 1.66, 95% CI: 1.46–1.90). After adjustment for disease severity, the risk of hip/femur fracture was no longer statistically significantly increased in inhaled GC users (adjusted OR 1.08, 95% CI: 0.91–1.27), whilst it remained elevated in oral GC users (adjusted OR 1.43, 95% CI: 1.22–1.67). Patients using inhaled GCs without any exposure to oral GCs had no increased risk of fracture (adjusted OR 0.98, 95% CI: 0.79–1.22). Conclusion. Inhaled GC users had no increased risk of femur/hip fracture after adjustment for underlying disease severity. Our data suggest that, even at higher dosages, inhaled GC use is not an independent risk factor for fracture. In contrast, oral GC use was associated with an increased risk of fracture, which was not fully explained by the underlying disease severity." @default.
• W2016029624 created "2016-06-24" @default.
• W2016029624 creator A5007926776 @default.
• W2016029624 creator A5016347038 @default.
• W2016029624 creator A5034083636 @default.
• W2016029624 creator A5035747289 @default.
• W2016029624 creator A5064427460 @default.
• W2016029624 creator A5086010333 @default.
• W2016029624 creator A5090520827 @default.
• W2016029624 date "2007-01-12" @default.
• W2016029624 modified "2023-10-13" @default.
• W2016029624 title "Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case?control study" @default.
• W2016029624 cites W1556508504 @default.
• W2016029624 cites W1815612258 @default.
• W2016029624 cites W1928668153 @default.
• W2016029624 cites W1945464131 @default.
• W2016029624 cites W1959913226 @default.
• W2016029624 cites W1982682585 @default.
• W2016029624 cites W1983391342 @default.
• W2016029624 cites W2014409436 @default.
• W2016029624 cites W2019022588 @default.
• W2016029624 cites W2033830300 @default.
• W2016029624 cites W2039493274 @default.
• W2016029624 cites W2039685990 @default.
• W2016029624 cites W2061819610 @default.
• W2016029624 cites W2081745439 @default.
• W2016029624 cites W2098761213 @default.
• W2016029624 cites W2102765172 @default.
• W2016029624 cites W2103013057 @default.
• W2016029624 cites W2105648357 @default.
• W2016029624 cites W2109428979 @default.
• W2016029624 cites W2121444149 @default.
• W2016029624 cites W2122906075 @default.
• W2016029624 cites W2124011858 @default.
• W2016029624 cites W2133390997 @default.
• W2016029624 cites W2142356382 @default.
• W2016029624 cites W2148371184 @default.
• W2016029624 cites W2156759282 @default.
• W2016029624 cites W2163739366 @default.
• W2016029624 cites W2185954894 @default.
• W2016029624 cites W2323830513 @default.
• W2016029624 cites W2334701948 @default.
• W2016029624 cites W4255533032 @default.
• W2016029624 doi "https://doi.org/10.1111/j.1365-2796.2006.01754.x" @default.
• W2016029624 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17241182" @default.
• W2016029624 hasPublicationYear "2007" @default.
• W2016029624 type Work @default.
• W2016029624 sameAs 2016029624 @default.
• W2016029624 citedByCount "69" @default.
• W2016029624 countsByYear W20160296242012 @default.
• W2016029624 countsByYear W20160296242013 @default.
• W2016029624 countsByYear W20160296242014 @default.
• W2016029624 countsByYear W20160296242015 @default.
• W2016029624 countsByYear W20160296242016 @default.
• W2016029624 countsByYear W20160296242017 @default.
• W2016029624 countsByYear W20160296242018 @default.
• W2016029624 countsByYear W20160296242019 @default.
• W2016029624 countsByYear W20160296242021 @default.
• W2016029624 countsByYear W20160296242023 @default.
• W2016029624 crossrefType "journal-article" @default.
• W2016029624 hasAuthorship W2016029624A5007926776 @default.
• W2016029624 hasAuthorship W2016029624A5016347038 @default.
• W2016029624 hasAuthorship W2016029624A5034083636 @default.
• W2016029624 hasAuthorship W2016029624A5035747289 @default.
• W2016029624 hasAuthorship W2016029624A5064427460 @default.
• W2016029624 hasAuthorship W2016029624A5086010333 @default.
• W2016029624 hasAuthorship W2016029624A5090520827 @default.
• W2016029624 hasBestOaLocation W20160296242 @default.
• W2016029624 hasConcept C126322002 @default.
• W2016029624 hasConcept C137627325 @default.
• W2016029624 hasConcept C141071460 @default.
• W2016029624 hasConcept C146304588 @default.
• W2016029624 hasConcept C162156334 @default.
• W2016029624 hasConcept C2776541429 @default.
• W2016029624 hasConcept C2778885795 @default.
• W2016029624 hasConcept C2780554211 @default.
• W2016029624 hasConcept C2992660301 @default.
• W2016029624 hasConcept C50440223 @default.
• W2016029624 hasConcept C71924100 @default.
• W2016029624 hasConceptScore W2016029624C126322002 @default.
• W2016029624 hasConceptScore W2016029624C137627325 @default.
• W2016029624 hasConceptScore W2016029624C141071460 @default.
• W2016029624 hasConceptScore W2016029624C146304588 @default.
• W2016029624 hasConceptScore W2016029624C162156334 @default.
• W2016029624 hasConceptScore W2016029624C2776541429 @default.
• W2016029624 hasConceptScore W2016029624C2778885795 @default.
• W2016029624 hasConceptScore W2016029624C2780554211 @default.
• W2016029624 hasConceptScore W2016029624C2992660301 @default.
• W2016029624 hasConceptScore W2016029624C50440223 @default.
• W2016029624 hasConceptScore W2016029624C71924100 @default.
• W2016029624 hasIssue "2" @default.
• W2016029624 hasLocation W20160296241 @default.
• W2016029624 hasLocation W20160296242 @default.
• W2016029624 hasLocation W20160296243 @default.
• W2016029624 hasOpenAccess W2016029624 @default.
• W2016029624 hasPrimaryLocation W20160296241 @default.
• W2016029624 hasRelatedWork W1985308509 @default.
• W2016029624 hasRelatedWork W2051350264 @default.

• next